ConductScience.org, home

Paper42930552PubMed

From Germ Cell Histogenesis to Precision Risk Stratification: Prognostic and Predictive Molecular Markers in Testicular Germ Cell Tumors-A Systematic Review.

Cutitaru AB and 4 others. Med Sci (Basel), 2026.

Cite this record

ConductScience Library. From Germ Cell Histogenesis to Precision Risk Stratification: Prognostic and Predictive Molecular Markers in Testicular Germ Cell Tumors-A Systematic Review. Papers, record 42930552. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42930552

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
From Germ Cell Histogenesis to Precision Risk Stratification: Prognostic and Predictive Molecular Markers in Testicular Germ Cell Tumors-A Systematic Review.
Journal
Med Sci (Basel)
Year
2026
Publication types
Journal Article, Systematic Review, Review
Revised in PubMed
2026-10-28

Source PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cutitaru ABAndrei Bogdanhttps://orcid.org/0009-0007-7304-445X
2Caruntu IDIrina Draga
3Balan RARaluca Ancahttps://orcid.org/0000-0003-2875-8991
4Solcan CCarmenhttps://orcid.org/0000-0002-0323-0296
5Amalinei CCorneliahttps://orcid.org/0000-0002-8228-104X

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Neoplasms, Germ Cell and EmbryonalMajor topic
Testicular NeoplasmsMajor topic
Biomarkers, TumorMajor topic
Humans
Male
Prognosis
Risk Assessment
MicroRNAs

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
SMIS code 351058The Health Programme (PS) 2021-2027PubMed

Source PubMed

Download CSV of grants

References115

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134446080The component of the m6A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumors.J Exp Clin Cancer Res2021https://conductscience.org/library/papers/34446080PubMed
240146282Diagnostic efficacy of serum microRNAs in predicting pathology of retroperitoneal lymph node dissection in patients with testicular germ cell tumors: a systematic review and meta-analysis.World J Urol2025https://conductscience.org/library/papers/40146282PubMed
312697874Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial.J Clin Oncol2003https://conductscience.org/library/papers/12697874PubMed
439134037[Testicular Germ Cell Tumours - features and prospects of the novel tumour marker microRNA-371a-3p (M371 test): a narrative review].Aktuelle Urol2024https://conductscience.org/library/papers/39134037PubMed
531583686Unique and redundant roles of SOX2 and SOX17 in regulating the germ cell tumor fate.Int J Cancer2020https://conductscience.org/library/papers/31583686PubMed
633822655Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium.J Clin Oncol2021https://conductscience.org/library/papers/33822655PubMed
729898407Integrated Molecular Characterization of Testicular Germ Cell Tumors.Cell Rep2018https://conductscience.org/library/papers/29898407PubMed
835390309Differential expression of preferentially expressed antigen in melanoma (PRAME) in testicular germ cell tumors - A comparative study with SOX17.Exp Mol Pathol2022https://conductscience.org/library/papers/35390309PubMed
939482699Refractory testicular germ cell tumors are highly sensitive to the targeting of polycomb pathway demethylases KDM6A and KDM6B.Cell Commun Signal2024https://conductscience.org/library/papers/39482699PubMed
1042202429
Serum levels of microRNA-371a-3p (M371) for prediction of histology in chemotherapy-naïve patients with testicular germ cell tumours undergoing lymph node dissection-a retrospective analysis of 57 cases.
Urol Oncol2026https://conductscience.org/library/papers/42202429PubMed
1138633762The epidemiology of cryptorchidism and potential risk factors, including endocrine disrupting chemicals.Front Endocrinol (Lausanne)2024https://conductscience.org/library/papers/38633762PubMed
1240025812Induction of SOX17 with stimulation of WNT, TGF-beta, and FGF signaling drives embryonal carcinomas into the yolk-sac tumor lineage resulting in increased cisplatin resistance.Int J Cancer2025https://conductscience.org/library/papers/40025812PubMed
1335181587MicroRNAs in Differentiation of Embryoid Bodies and the Teratoma Subtype of Testicular Cancer.Cancer Genomics Proteomics2022https://conductscience.org/library/papers/35181587PubMed
1442131333TNFSF10: a promising prognostic biomarker and therapeutic target for immunotherapy in testicular germ cell tumors.Front Immunol2026https://conductscience.org/library/papers/42131333PubMed
1519390421SALL4 is a novel diagnostic marker for testicular germ cell tumors.Am J Surg Pathol2009https://conductscience.org/library/papers/19390421PubMed
1638541652RAS/Mitogen-Activated Protein Kinase Signaling Pathway in Testicular Germ Cell Tumors.Life (Basel)2024https://conductscience.org/library/papers/38541652PubMed
179060597Trophoblastic tumors of the testis other than classic choriocarcinoma: "monophasic" choriocarcinoma and placental site trophoblastic tumor: a report of two cases.Am J Surg Pathol1997https://conductscience.org/library/papers/9060597PubMed
1840998685MicroRNA as a Liquid Biomarker to Detect Malignancy in Small Testicular Masses.Eur Urol Oncol2025https://conductscience.org/library/papers/40998685PubMed
1941749828Comparative Analysis of the Transcriptomic Response to Cisplatin in Drug-Sensitive and Drug-Resistant Testicular Germ Cell Tumors.Cancers (Basel)2026https://conductscience.org/library/papers/41749828PubMed
2027905446Genomic evolution and chemoresistance in germ-cell tumours.Nature2016https://conductscience.org/library/papers/27905446PubMed

See all 115 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42930552

GET https://conductscience.org/api/papers/v1/42930552/references?page=2